Breyer Capital 2026 Healthcare and Life Sciences Predictions

January 21, 2026

Breyer Capital’s Principles for the Future of Healthcare and Life Sciences

June 26, 2025

A Collective Vision for 23andMe

January 20, 2025

Fulcrum Points

January 08, 2025

Why AI Is Good for Our Health but May Hurt Our Wallets

December 15, 2024

What should happen to 23andMe?

October 10, 2024

Healthcare AI Thesis Update

September 26, 2024

Who Pays for Healthcare AI - Performance-Based Pricing Models (Part III)

September 12, 2024

Who Pays for Healthcare AI (Part II)

February 13, 2024

Who Pays for Healthcare AI? (Part I)

January 17, 2024

Six imperatives for AI-first companies

December 07, 2023

The Faster Horse Problem in AI

November 14, 2023

Put your healthcare AI app to the test

June 08, 2023

Command Line Medicine

May 11, 2023

Chapter Three: Reductions in Force (RIF)

February 06, 2023

Chapter Two: Performance Improvement Plans (PIPs) 101

October 19, 2022

The Anatomy of the Data Room

October 13, 2022

Direct-to-clinician: How product-led growth is transforming healthcare and life sciences

October 05, 2022

Direct-to-clinician—How product-led growth is changing healthcare and life sciences

September 28, 2022

The Evolving Healthcare Product Landscape

September 14, 2022

Chapter One: Feedback Conversations

July 12, 2022

Demonstrating Clinical Outcomes as a Care Delivery Company

May 24, 2022

Payer Contracting Best Practices for Virtual Care Companies

April 14, 2022

Welcome!

May 29, 2021

welcome!

May 29, 2021